The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

@article{Pitt1999TheEO,
  title={The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.},
  author={Bertram Pitt and Faiez Zannad and Willem J. Remme and Rosemary Cody and Alain Castaigne and Alberto Luis Rodrigues Perez and Jolie Palensky and Janet Wittes},
  journal={The New England journal of medicine},
  year={1999},
  volume={341 10},
  pages={
          709-17
        }
}
  • Bertram Pitt, Faiez Zannad, +5 authors Janet Wittes
  • Published 1999
  • Medicine
  • The New England journal of medicine
  • BACKGROUND AND METHODS Aldosterone is important in the pathophysiology of heart failure. In a doubleblind study, we enrolled 1663 patients who had severe heart failure and a left ventricular ejection fraction of no more than 35 percent and who were being treated with an angiotensin-converting-enzyme inhibitor, a loop diuretic, and in most cases digoxin. A total of 822 patients were randomly assigned to receive 25 mg of spironolactone daily, and 841 to receive placebo. The primary end point was… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to determine if patients who receive an early radiofrequency ablation will have fewer hospitalizations, unplanned office visits, and emergency room visits… Expand
    ConditionsHeart Failure With Preserved Ejection Fraction
    InterventionProcedure
    INTERVENTIONAL CLINICAL TRIAL
    Hypertrophic Cardiomyopathy (HCM) is the most common hereditary heart disease with high mortality. Heart failure is the most common complication (about 50% incidence) in these… Expand
    ConditionsFibrosis, Hypertrophic Cardiomyopathy
    InterventionDrug
    BLOG POST
    INTERVENTIONAL CLINICAL TRIAL
    In stage 3 chronic kidney disease (CKD) the risk of death due to cardiovascular causes is high and greatly exceeds the risk of progression to end stage renal failure. This high… Expand
    ConditionsCardio-Renal Syndrome, Renal Insufficiency, Chronic
    InterventionDrug

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 2,640 CITATIONS, ESTIMATED 43% COVERAGE

    FILTER CITATIONS BY YEAR

    1996
    2020

    CITATION STATISTICS

    • 79 Highly Influenced Citations

    • Averaged 196 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES